blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1784213

EP1784213 - IMPROVEMENTS RELATING TO MENINGOCOCCAL OUTER MEMBRANE VESICLES [Right-click to bookmark this link]
Former [2007/20]IMPROVEMENTS RELATING TO MENINGOCOCCAL OUTER MEMBRANE VESICLES
[2014/44]
StatusNo opposition filed within time limit
Status updated on  04.09.2015
Database last updated on 14.09.2024
Most recent event   Tooltip13.10.2017Lapse of the patent in a contracting state
New state(s): BG, HU, TR
published on 15.11.2017  [2017/46]
Applicant(s)For all designated states
Novartis Vaccines and Diagnostics S.r.l.
Via Fiorentina 1
53100 Siena (SI) / IT
[2014/44]
Former [2007/20]For all designated states
Novartis Vaccines and Diagnostics S.r.l.
Via Fiorentina 1
53100 Siena SI / IT
Inventor(s)01 / OSTER, Philipp
Chiron Vaccines
Via Fiorentina, 1
I-53100 Siena / IT
02 / RAPPUOLI, Rino
Novartis Vaccines
Via Fiorentina, 1
I-53100 Siena / IT
03 / PIZZA, Mariagrazia
Novartis Vaccines
Via Fiorentina, 1
I-53100 Siena / IT
 [2014/44]
Former [2007/20]01 / OSTER, Philipp
Chiron Vaccines Via Fiorentina, 1
I-53100 Siena / IT
02 / RAPPUOLI, Rino
Novartis Vaccines Via Fiorentina, 1
I-53100 Siena / IT
03 / PIZZA, Mariagrazia
Novartis Vaccines Via Fiorentina, 1
I-53100 Siena / IT
Representative(s)Marshall, Cameron John, et al
Carpmaels & Ransford LLP
One Southampton Row
London WC1B 5HA / GB
[2014/44]
Former [2007/20]Marshall, Cameron John, et al
Carpmaels & Ransford 43-45 Bloomsbury Square
London WC1A 2RA / GB
Application number, filing date05782411.205.09.2005
[2014/44]
WO2005IB02801
Priority number, dateGB2004001962703.09.2004         Original published format: GB 0419627
[2007/20]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2006024946
Date:09.03.2006
Language:EN
[2006/10]
Type: A2 Application without search report 
No.:EP1784213
Date:16.05.2007
Language:EN
The application published by WIPO in one of the EPO official languages on 09.03.2006 takes the place of the publication of the European patent application.
[2007/20]
Type: B1 Patent specification 
No.:EP1784213
Date:29.10.2014
Language:EN
[2014/44]
Search report(s)International search report - published on:EP30.11.2006
ClassificationIPC:A61K39/095
[2007/20]
CPC:
A61K39/095 (EP,US); A61P31/00 (EP); A61P31/04 (EP);
A61P37/04 (EP); A61K2039/545 (EP,US); A61K2039/55555 (EP,US)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2007/20]
Extension statesAL15.03.2007
BA15.03.2007
HR15.03.2007
MK15.03.2007
YU15.03.2007
TitleGerman:VERBESSERUNGEN BEZÜGLICH MENINGOCOCCALE AUSSENMEMBRANPROTEINEN[2014/44]
English:IMPROVEMENTS RELATING TO MENINGOCOCCAL OUTER MEMBRANE VESICLES[2014/44]
French:AMELIORATIONS EN RAPPORT AVEC LES VESICULES DE LA MEMBRANE EXTERIEURE DE MENINGOCOQUE[2014/44]
Former [2007/20]VERBESSERUNGEN BEZÜGLICH MENINGOCOCCALE AUSSENMEMBRANPROTEINEN
Former [2007/20]IMPROVEMENTS RELATING TO MENINGOCOCCAL OUTER MEMBRANE VESICLES
Former [2007/20]AMELIORATIONS EN RAPPORT AVEC LES VESICULES DE LA MEMBRANE EXTERIEURE DE MENINGOCOQUE
Entry into regional phase15.03.2007National basic fee paid 
15.03.2007Designation fee(s) paid 
15.03.2007Examination fee paid 
Examination procedure15.03.2007Amendment by applicant (claims and/or description)
15.03.2007Examination requested  [2007/20]
17.06.2010Despatch of a communication from the examining division (Time limit: M06)
14.12.2010Reply to a communication from the examining division
21.05.2012Despatch of a communication from the examining division (Time limit: M06)
30.11.2012Reply to a communication from the examining division
23.06.2014Communication of intention to grant the patent
18.09.2014Fee for grant paid
18.09.2014Fee for publishing/printing paid
18.09.2014Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  17.06.2010
Opposition(s)30.07.2015No opposition filed within time limit [2015/41]
Fees paidRenewal fee
15.03.2007Renewal fee patent year 03
31.03.2008Renewal fee patent year 04
11.09.2009Renewal fee patent year 05
14.09.2010Renewal fee patent year 06
29.09.2011Renewal fee patent year 07
12.09.2012Renewal fee patent year 08
12.09.2013Renewal fee patent year 09
12.09.2014Renewal fee patent year 10
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU05.09.2005
AT29.10.2014
BG29.10.2014
CY29.10.2014
CZ29.10.2014
DK29.10.2014
EE29.10.2014
FI29.10.2014
LT29.10.2014
LV29.10.2014
MC29.10.2014
NL29.10.2014
PL29.10.2014
RO29.10.2014
SE29.10.2014
SI29.10.2014
SK29.10.2014
TR29.10.2014
GR30.01.2015
IS28.02.2015
PT02.03.2015
[2017/39]
Former [2016/23]AT29.10.2014
CY29.10.2014
CZ29.10.2014
DK29.10.2014
EE29.10.2014
FI29.10.2014
LT29.10.2014
LV29.10.2014
MC29.10.2014
NL29.10.2014
PL29.10.2014
RO29.10.2014
SE29.10.2014
SI29.10.2014
SK29.10.2014
GR30.01.2015
IS28.02.2015
PT02.03.2015
Former [2016/12]AT29.10.2014
CY29.10.2014
CZ29.10.2014
DK29.10.2014
EE29.10.2014
FI29.10.2014
LT29.10.2014
LV29.10.2014
NL29.10.2014
PL29.10.2014
RO29.10.2014
SE29.10.2014
SI29.10.2014
SK29.10.2014
GR30.01.2015
IS28.02.2015
PT02.03.2015
Former [2015/37]AT29.10.2014
CY29.10.2014
CZ29.10.2014
DK29.10.2014
EE29.10.2014
FI29.10.2014
LT29.10.2014
LV29.10.2014
NL29.10.2014
PL29.10.2014
RO29.10.2014
SE29.10.2014
SK29.10.2014
GR30.01.2015
IS28.02.2015
PT02.03.2015
Former [2015/36]AT29.10.2014
CY29.10.2014
CZ29.10.2014
DK29.10.2014
EE29.10.2014
FI29.10.2014
LT29.10.2014
LV29.10.2014
NL29.10.2014
PL29.10.2014
RO29.10.2014
SE29.10.2014
GR30.01.2015
IS28.02.2015
PT02.03.2015
Former [2015/35]AT29.10.2014
CY29.10.2014
DK29.10.2014
EE29.10.2014
FI29.10.2014
LT29.10.2014
LV29.10.2014
NL29.10.2014
PL29.10.2014
SE29.10.2014
GR30.01.2015
IS28.02.2015
PT02.03.2015
Former [2015/34]AT29.10.2014
CY29.10.2014
DK29.10.2014
FI29.10.2014
LT29.10.2014
LV29.10.2014
NL29.10.2014
PL29.10.2014
SE29.10.2014
GR30.01.2015
IS28.02.2015
PT02.03.2015
Former [2015/26]AT29.10.2014
CY29.10.2014
FI29.10.2014
LT29.10.2014
LV29.10.2014
NL29.10.2014
PL29.10.2014
SE29.10.2014
GR30.01.2015
IS28.02.2015
PT02.03.2015
Former [2015/25]AT29.10.2014
FI29.10.2014
LT29.10.2014
LV29.10.2014
NL29.10.2014
PL29.10.2014
SE29.10.2014
GR30.01.2015
IS28.02.2015
PT02.03.2015
Former [2015/24]FI29.10.2014
LT29.10.2014
LV29.10.2014
NL29.10.2014
PL29.10.2014
SE29.10.2014
GR30.01.2015
IS28.02.2015
PT02.03.2015
Former [2015/23]FI29.10.2014
LT29.10.2014
NL29.10.2014
IS28.02.2015
PT02.03.2015
Former [2015/22]LT29.10.2014
PT02.03.2015
Former [2015/20]LT29.10.2014
Cited inInternational search[X]WO0209643  (CHILDREN S HOSPITAL OAKLAND RE [US], et al) [X] 1-10,19-24,29-36,40,41,47 * page 22, line 21 - page 25, line 8; claims 14,15,29,30 *;
 [X]WO03105890  (GLAXOSMITHKLINE BIOLOG SA [BE], et al) [X] 29-36,40,41 * page 14, line 4 - line 20; claims 1,12,13 * * page 4, line 3 - line 9 *;
 [Y]WO2004054611  (NASJONALT FOLKEHELSEINSTITUTT [NO], et al) [Y] 1-10,19-24,29-36,47 * page 15, line 26 - page 16, line 9; claims 1,15 *;
 [Y]WO2004019977  (CHIRON SRL [IT], et al) [Y] 1-10,19-24,29-36,47 * page 2, line 1 - page 3, line 18 *;
 [Y]WO2004014418  (GLAXOSMITHKLINE BIOLOG SA [BE], et al) [Y] 40,41 * page 25, line 30 - page 28, line 2 * * page 40, line 7 - line 17 *;
 [Y]WO2004048404  (CHIRON SRL [IT], et al) [Y] 40,41 * page 22, line 1 - line 30 *
 [Y]  - NORHEIM G ET AL, "Immunogenicity and bactericidal activity in mice of an outer membrane protein vesicle vaccine against Neisseria meningitidis serogroup A disease", VACCINE, BUTTERWORTH SCIENTIFIC. GUILDFORD, GB, (20040602), vol. 22, no. 17-18, ISSN 0264-410X, pages 2171 - 2180, XP004508733 [Y] 1-10,19-24,29-36,47 * abstract *

DOI:   http://dx.doi.org/10.1016/j.vaccine.2003.11.047
 [Y]  - PEETERS C C A M ET AL, "Phase I clinical trial with a hexavalent PorA containing meningococcal outer membrane vesicle vaccine", VACCINE, (1996), vol. 14, no. 10, ISSN 0264-410X, pages 1009 - 1015, XP004057633 [Y] 1-10,19-24,29-36,47 * abstract *

DOI:   http://dx.doi.org/10.1016/0264-410X(96)00001-1
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.